News
With new at-home STI testing and GLP-1 weight care, Wisp is building a category-defining digital telehealth platform for ...
18h
MedPage Today on MSNEnd of Compounded Semaglutide; 464M Teens Will Have Obesity; GLP-1 Scripts SkyrocketResearchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...
Gabby tried a variety of weight loss methods, without results. She also found out that because of her past health issues, she ...
With VKTX surging on clinical results and NVO investing to cement market share, investors face a high-stake GLP-1 showdown.
Blue Cross plans are retreating from GLP-1 weight-loss drug coverage after spending hundreds of millions of dollars on the ...
GLP-1 receptor agonists may modestly reduce the risk for 14 obesity-related cancers, especially colorectal cancer, among ...
Researchers are working to make GLP-1 medications like Ozempic and Wegovy available to consumers as pills, instead of being produced as solely inject-able treatments.
New data from digital marketing agency Sagapixel reveals that public interest in the term “GLP-1” has officially surpassed search volume for “Ozempic” — marking a fundamental shift in how patients ...
Ozempic, a GLP-1 drug, has been a game-changer for many, including the author, allowing them to enjoy their pregnancy without ...
In 2024, 4% of U.S. adults were prescribed a GLP-1 therapy — a 363.7% increase from 0.9% in 2019, according to a Fair Health analysis of more than 51 billion commercial claim records. Fair Health ...
GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...
As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results